Complete Filing Data
Fidelity Ethereum Fund reported Assets Net of $2.21 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fidelity Ethereum Fund did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Profit Loss | -$422.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Profit Loss | $873.0M | $247.2M | -$665.3M | -$58.6M | -$383.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Assets Net | $2.21B | $1.57B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 |
| Unrealized Gain Loss On Investments | $128.0M | |
| Gain Loss On Investments | -$417.7M | |
| Stockholders Equity Period Increase Decrease | $637.1M | |
| Stockholders Equity | $2.21B | $1.57B |
| Retained Earnings Accumulated Deficit | -$431.4M | -$9.1M |
| Liabilities | $2.7M | $31.8M |
| Common Stock Value | $0.00 | $0.00 |
| Assets | $2.21B | $1.60B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | |
| Receivable Investment Sale | $0.00 | $31.8M |
| Gain Loss On Sale Of Trust Assets To Pay Expenses | -$786.0K | |
| Payable For Purchases Of Investments | ||
| Accounts Payable Current And Noncurrent | ||
| Payable Investment Purchase | $0.00 | $31.8M |
| Payable Common Stock Redeemed | $2.2M | $0.00 |
| Non Cash Issuances Of Capital Shares Value | 55.0M | |
| Management Fee Payable | $457.0K | $0.00 |
| Accounts And Other Receivables Net Current | $2.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Assets Net | $3.15B | $1.24B | $733.9M | $424.5M | $4.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Unrealized Gain Loss On Investments | $972.1M | $394.7M | -$484.7M | -$56.5M | -$383.0K | |
| Gain Loss On Investments | $874.8M | $247.8M | -$664.6M | -$58.6M | -$383.0K | |
| Stockholders Equity Period Increase Decrease | $1.91B | $505.6M | -$838.7M | $420.1M | $4.4M | |
| Stockholders Equity | $3.15B | $1.24B | $733.9M | $424.5M | $4.4M | |
| Retained Earnings Accumulated Deficit | $445.7M | -$427.3M | -$674.4M | -$59.0M | -$383.0K | |
| Liabilities | $662.0K | $25.9M | $6.6M | $0.00 | $0.00 | |
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Assets | $3.15B | $1.27B | $740.5M | $424.5M | $4.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | $0.00 | $0.00 | |||
| Receivable Investment Sale | $0.00 | $25.7M | $6.4M | |||
| Gain Loss On Sale Of Trust Assets To Pay Expenses | -$199.0K | -$235.0K | $0.00 | $0.00 | ||
| Payable For Purchases Of Investments | $0.00 | $25.7M | $6.4M | $31.8M | ||
| Accounts Payable Current And Noncurrent | $662.0K | $239.0K | $159.0K | $0.00 | ||
| Payable Investment Purchase | ||||||
| Payable Common Stock Redeemed | ||||||
| Non Cash Issuances Of Capital Shares Value | ||||||
| Management Fee Payable | ||||||
| Accounts And Other Receivables Net Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Increase Decrease In Operating Assets | -$422.3M |
| Proceeds From Issuance Of Common Stock | $4.30B |
| Payments For Repurchase Of Common Stock | $3.26B |
| Payments For Purchase Of Investment Operating Activity | $4.30B |
| Net Cash Provided By Used In Operating Activities | -$1.04B |
| Net Cash Provided By Used In Financing Activities | $1.04B |
| Proceeds From Disposition Of Investment Operating Activity | $3.26B |
| Increase Decrease In Accounts Payable Related Parties | $457.0K |
| Increase Decrease In Management Fee Payable |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Increase Decrease In Operating Assets | $873.0M | $247.2M | -$665.3M | -$58.6M | -$383.0K |
| Proceeds From Issuance Of Common Stock | $381.8M | $488.8M | $4.8M | ||
| Payments For Repurchase Of Common Stock | $529.8M | $5.3M | $0.00 | ||
| Payments For Purchase Of Investment Operating Activity | $381.8M | $488.8M | $4.8M | ||
| Net Cash Provided By Used In Operating Activities | $148.0M | -$483.5M | -$4.8M | ||
| Net Cash Provided By Used In Financing Activities | -$148.0M | $483.5M | $4.8M | ||
| Proceeds From Disposition Of Investment Operating Activity | $529.8M | $5.3M | $0.00 | ||
| Increase Decrease In Accounts Payable Related Parties | $0.00 | ||||
| Increase Decrease In Management Fee Payable | $159.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Shares Outstanding | ||
| Net Asset Value Per Share | $29.64 | $33.34 |
| Common Stock Shares Outstanding | 74.6M | 47.2M |
| Common Stock Shares Issued | 74.6M | 47.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Shares Outstanding | 76.5M | 49.9M | 40.0M | 47.2M | 16.2M | 125.0K |
| Net Asset Value Per Share | $41.23 | $24.83 | $18.34 | $26.28 | $34.94 | |
| Common Stock Shares Outstanding | 76.5M | 49.9M | 40.0M | 16.2M | 125.0K | |
| Common Stock Shares Issued | 76.5M | 49.9M | 40.0M | 16.2M | 125.0K | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Sponsor Fees | $4.6M | |
| Realized Investment Gains Losses | -$544.9M | |
| Net Investment Income | -$4.6M | |
| Investment Income Interest | $0.00 | |
| Stock Repurchased And Retired During Period Shares | 98.7M | |
| Stock Redeemed Or Called During Period Value | $3.40B | |
| Stock Issued During Period Value New Issues | $4.46B | |
| Stock Issued During Period Shares Period Increase Decrease | 27.4M | |
| Stock Issued During Period Shares New Issues | 126.1M | |
| Investment Owned At Fair Value | $2.21B | $1.57B |
| Investment Company Increase Decrease From Share Transaction | $1.06B | |
| Investment Owned At Cost | $2.05B | $1.54B |
| Additional Paid In Capital | $2.64B | $1.58B |
| Operating Costs And Expenses | $4.6M | |
| Investment Company Expense Offset Arrangement | $0.00 | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $4.6M | |
| Transfer Of Ether To Pay The Sponsor Fee | $4.1M | |
| Investment Income Net | -$4.6M | |
| Realized Gain Loss Security Sold Short Operating | -$544.9M | |
| Net Realized Gain Loss On Investment In Ether Transferred To Pay The Sponsor Fee |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Sponsor Fees | $1.8M | $603.0K | $666.0K | $139.0K | $0.00 |
| Realized Investment Gains Losses | -$97.2M | -$146.7M | -$179.7M | -$2.1M | $0.00 |
| Net Investment Income | -$1.8M | -$603.0K | -$666.0K | $0.00 | $0.00 |
| Investment Income Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock Repurchased And Retired During Period Shares | 41.2M | 14.3M | 19.5M | 350.0K | 1.00 |
| Stock Redeemed Or Called During Period Value | $1.70B | $312.7M | $538.6M | $9.5M | $0.00 |
| Stock Issued During Period Value New Issues | $2.74B | $571.1M | $365.2M | $488.2M | $4.8M |
| Stock Issued During Period Shares Period Increase Decrease | 26.6M | 9.9M | -7.2M | 16.0M | 125.0K |
| Stock Issued During Period Shares New Issues | 67.8M | 24.2M | 12.4M | 16.4M | 125.0K |
| Investment Owned At Fair Value | $3.15B | $1.24B | $734.1M | $424.5M | $4.4M |
| Investment Company Increase Decrease From Share Transaction | $1.04B | $258.4M | -$173.4M | $478.8M | $4.8M |
| Investment Owned At Cost | $2.24B | $1.30B | $1.19B | $481.4M | $4.8M |
| Additional Paid In Capital | $2.71B | $1.67B | $1.41B | $483.5M | $4.8M |
| Operating Costs And Expenses | $1.8M | $139.0K | $0.00 | ||
| Investment Company Expense Offset Arrangement | $0.00 | $139.0K | $0.00 | ||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $1.8M | $0.00 | $0.00 | ||
| Transfer Of Ether To Pay The Sponsor Fee | $507.0K | $0.00 | |||
| Investment Income Net | -$666.0K | $0.00 | $0.00 | ||
| Realized Gain Loss Security Sold Short Operating | |||||
| Net Realized Gain Loss On Investment In Ether Transferred To Pay The Sponsor Fee | -$223.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.